following SHANK1 or SHANK3 silencing in 9 and in 5 out of the 13 cell lines tested, respectively (Fig. 1a ). Although both SHANK1 and SHANK3 are major PSD scaffolding proteins in excitatory METHODS Cell culture. CHO (Chinese hamster ovary) cells were maintained in Alpha-MEM medium (Sigma-Aldrich) supplemented with 5% fetal bovine serum (FBS, Gibco) and 2 mM L-glutamine (Sigma-Aldrich). HEK293 (human embryonic kidney, ATCC) cells were grown in DMEM (Dulbecco's modified Eagle's medium, Sigma-Aldrich) supplemented with 10% FBS and 2 mM L-glutamine. MDA-MB-231 (triplenegative human breast adenocarcinoma, ATCC) cells were maintained in DMEM supplemented with 10% FBS, 2 mM L-glutamine, and 1% non-essential amino acids (Sigma-Aldrich). Immortalized mouse embryonic fibroblasts (MEFs) isolated from wild-type and SHARPIN -null (cpdm) mice have been described previously 7 . MEFs were cultured in DMEM supplemented with 10% FBS, 2 mM L-glutamate, 1 mM sodium pyruvate (Sigma-Aldrich), 1% non-essential amino acids and 1:100,000 β-mercaptoethanol (Sigma-Aldrich). SK-N-BE-2 neuroblastoma cells (ATCC) were maintained in DMEM:HAM's F-12 medium supplemented with 10% FBS, 2 mM glutamine and 1% non-essential amino acids. All cells were routinely tested for mycoplasma contamination. No cell lines used in this study were found in the database of commonly misindentified cell lines that is maintained by ICLAC and NCBI Biosample. The cell lines were not authenticated.
SHANK proteins limit integrin activation by directly interacting with Rap1 and R-Ras
SHANK3, a synaptic scaffold protein and actin regulator, is widely expressed outside of the central nervous system with predominantly unknown function. Solving the structure of the SHANK3 N-terminal region revealed that the SPN domain is an unexpected Ras-association domain with high affinity for GTP-bound Ras and Rap G-proteins. The role of Rap1 in integrin activation is well established but the mechanisms to antagonize it remain largely unknown. Here, we show that SHANK1 and SHANK3 act as integrin activation inhibitors by sequestering active Rap1 and R-Ras via the SPN domain and thus limiting their bioavailability at the plasma membrane. Consistently, SHANK3 silencing triggers increased plasma membrane Rap1 activity, cell spreading, migration and invasion. Autism-related mutations within the SHANK3 SPN domain (R12C and L68P) disrupt G-protein interaction and fail to counteract integrin activation along the Rap1-RIAM-talin axis in cancer cells and neurons. Altogether, we establish SHANKs as critical regulators of G-protein signalling and integrin-dependent processes.
Integrins are heterodimeric transmembrane receptors that couple the extracellular matrix (ECM) to the actin cytoskeleton and undergo conformational switching from a low-affinity 'inactive' to a high-affinity 'active' state. In the active conformation integrins enhance cell signalling and inappropriate integrin activation is linked to several pathologies including inflammation and cancer 1 . Hence, understanding integrin activity regulation is of major clinical relevance. Integrins are also crucial regulators of important processes in the brain such as neuronal cell migration, axonal outgrowth and synaptic plasticity 2 but the role of integrin activity regulation in these processes remains to be fully investigated.
Talin recruitment to the β-integrin tail triggers integrin activation and is regulated through the activity of the Rap1 GTPase and its effector Rap1-interacting adaptor molecule (RIAM) [3] [4] [5] . Integrin activity can be counterbalanced by integrin-inactivating proteins such as SHARPIN, ICAP-1 and filamin 1, 6, 7 , all of which interact with integrins and directly or indirectly interfere with talin-mediated integrin activation. However, potential mechanisms to block integrin activation at the level of Rap G proteins remain unidentified.
SH3 and multiple ankyrin repeat domains (SHANK) 1-3 are a family of scaffold proteins found in the postsynaptic density (PSD) of excitatory synapses and are indispensable for normal brain function 8,9 . In addition, SHANK proteins are expressed in peripheral organs with largely unknown functions. Genetic alterations in SHANK3 are responsible for a spectrum of neuropsychiatric disorders, including autism spectrum disorders (ASDs), schizophrenia, intellectual disability and manic-like behaviour [10] [11] [12] [13] [14] [15] [16] and chromosomal deletions of the region containing SHANK3 cause Phelan-McDermid syndrome (22q13 deletion syndrome), which manifests as neurological symptoms and affects many peripheral organs including the dermis, congruent with the wide tissue distribution of SHANK3 17, 18 . Recently, autism-like symptoms of Shank3-deficient mice were reversed by targeting actin regulators or Akt signalling 19, 20 and adult restoration of Shank3 in mice improved many of the autistic-like symptoms 21 . Thus, SHANK3 seems to actively contribute to signalling and the regulation of the cell cytoskeleton during and post development.
RESULTS

SHANK1 and SHANK3 inhibit integrin activation
We previously performed a druggable genome-wide RNA-mediated interference (RNAi) screen in 13 different human cell lines and analysed integrin activity using monoclonal anti-β1-integrin antibodies Statistics source data can be found in Supplementary Table 3 . Unprocessed original scans of blots are shown in Supplementary Fig. 8 .
(9EG7 and 12G10) that specifically recognize the active receptor conformation 22 . Re-evaluation of these data revealed increased integrin activation (detected with either one or both of the antibodies) synapses, they are also widely expressed outside of the nervous system with currently unknown functions (publicly available GTEx portal data; Fig. 1b ).
To validate a role for SHANK1 and SHANK3 in inhibiting integrin activation we employed a dual-colour flow cytometric assay to measure cell-surface active integrins (based on the binding of a recombinant integrin ligand fragment, fibronectin (FN) repeats 7-10) relative to total cell-surface integrins in CHO cells 23, 24 . Expression of rat Shank3-mRFP ( Fig. 1c ) or rat Shank1-GFP ( Supplementary Fig. 1a ) significantly reduced integrin activity, compared with mRFP or GFP alone ( Fig. 1c and Supplementary  Fig. 1a ) without altering total β1-integrin surface levels. Moreover, the magnitude of Shank-mediated integrin inhibition was comparable to the effect of overexpressing SHARPIN-GFP ( Fig. 1c ), a known β1-integrin inhibitor in several cell types 7, 25, 26 . To confirm these findings we analysed integrin activity in the human HEK293 and MDA-MB-231 cell lines with opposing patterns of SHANK3 and SHANK1 expression ( Supplementary Fig. 1b ,c). Silencing of SHANK3 in SHANK3-expressing HEK293 cells or SHANK1 in SHANK1expressing MDA-MB-231 cells ( Supplementary Fig. 1d ) triggered a significant increase in cell-surface active integrin levels (Fig. 1d ,e and Supplementary Fig. 1e ,f) without affecting total cell-surface receptor expression. SHANK3, or SHANK1, silencing was nearly as efficient in activating β1-integrins as Mn 2+ ( Fig. 1d and Supplementary  Fig. 1e ), which binds to the integrin ectodomain and activates β1-integrin heterodimers via an outside-in mechanism 27 . Importantly, reintroduction of rat Shank3-mRFP or rat Shank1-GFP reversed the increased integrin activity in SHANK3-or SHANK1-silenced cells and reduced integrin activity levels in control-silenced cells ( Fig. 1e and Supplementary Fig. 1f ). Thus, the ability of SHANK3-and SHANK1targeted short interfering RNA (siRNA; siSHANK3 and siSHANK1, respectively) to increase β1-integrin activity was specifically due to the loss of each SHANK isoform rather than off-target effects.
To explore whether murine Shank3 regulates integrin activity as well, we isolated mouse mammary epithelial cells (MMECs), known to express Shank3 28 ( Supplementary Fig. 1g ), and mouse mammary fibroblasts (MMFs) lacking Shank3 ( Supplementary Fig. 1g ), from WT Shank3αβ +/+ and Shank3αβ −/− mutant mice (specifically lacking the long α (containing SPN, Ank and SH3 domains) and β (containing Ank and SH3 domains) isoforms of SHANK3) 29, 30 . We observed markedly higher active integrin levels in MMECs, but not MMFs, isolated from Shank3αβ −/− compared with WT mice (Shank3αβ +/+ ) ( Fig. 1f and Supplementary Fig. 1h ,i). Taken together, these data indicate that SHANK1 and SHANK3 function as inhibitors of β1-integrin activation.
SHANK1 and SHANK3 localize to membrane ruffles with inactive integrins
Next we investigated the subcellular localization of SHANKs in cells. In the absence of suitable reagents to detect endogenous SHANKs with immunofluorescence we expressed Shank3-mRFP ( Fig. 1g and Supplementary Fig. 1j ,k) or Shank1-GFP in MDA-MB-231 cells ( Supplementary Fig. 1j ). Both SHANK proteins localized to the periphery of the cell in actin-rich membrane ruffles positive for the membrane marker CAAX-GFP and the inactive integrin receptor ( Fig. 1g and Supplementary Fig. 1j ) as well as to the nucleus (the possible nuclear function of SHANKs was not investigated here further). Conversely, no co-localization was observed between SHANKs and ECM-bound active integrins ( Supplementary Fig. 1k ). Membrane recruitment of SHANK3 was validated further with biochemical membrane fractionation, demonstrating SHANK3 in both the cytoplasmic and plasma membrane fractions (Fig. 1h ), and with live-cell imaging showing dynamic localization of Shank3-mRFP to folding membrane areas ( Fig. 1i and Supplementary Video 1). Thus, SHANK1 and SHANK3 appear to predominantly localize to unattached membrane ruffles together with inactive integrin and actin.
SHANK1 and SHANK3 inhibit cell adhesion and spreading
Consistent with increased integrin activation ( Fig. 1 ), SHANK3 silencing in HEK293 cells or SHANK1 silencing in MDA-MB-231 cells promoted cell adhesion to a fibronectin-collagen matrix over time as measured with the xCELLigence apparatus ( Fig. 2a and Supplementary Fig. 2a ). In addition, SHANK3-silenced HEK293 cells generated significantly more, yet smaller, adhesions ( Fig. 2b-e ). Interestingly, SHANK3 silencing also appeared to affect cell spreading. Downregulation of either SHANK isoform was sufficient to trigger a significant increase in cell area on the fibronectin-collagen-coated surface at 20 and 60 min post-plating compared with controlsilenced cells (Fig. 2f,g and Supplementary Fig. 2b,c ). Enhanced cell spreading was even more evident in cells plated on spatially restricted micropattern lines where SHANK3 silencing resulted in significantly longer cell lengths compared with the control (Fig. 2h ,i). Thus, SHANK1 and SHANK3 negatively regulate integrin-mediated adhesion and spreading in cells.
SHANK-mediated integrin inhibition is SHARPIN independent
We next sought to explore how SHANKs regulate integrin activity. SHARPIN binds to the ARR domain of SHANKs 31, 32 . To determine whether SHANK-mediated integrin inactivation is SHARPIN dependent, we expressed SHARPIN-or Shank1-GFP in mouse embryonic fibroblasts (MEFs) generated from WT or SHARPIN-null (cpdm) animals 7 and measured surface levels of active (FN7-10 binding), relative to total, β1-integrin. As expected, expression of both SHARPIN-GFP and Shank1-GFP reduced β1-integrin activation in WT MEFs ( Supplementary Fig. 2d ). Interestingly, Shank1-GFP expression decreased β1-integrin activation in cpdm MEFs to approximately the same extent as in WT MEFs ( Supplementary  Fig. 2d ) suggesting that SHARPIN is dispensable for SHANKmediated integrin inactivation.
Autism-linked mutations in SHANK3 impair its integrin inhibitory function
The amino-terminal SPN domain of SHANK1 and SHANK3 ( Fig. 3a ) is highly conserved 32 and missense mutations in the SPN domain of SHANK3 (R12C and L68P) have been detected in patients with autism 33, 34 , highlighting the importance of the SPN domain for the proper function of SHANK3. In line with this notion, we found that expression of SHANK mutants (Shank3R12C or Shank3L68P) harbouring the identified ASD mutations 32 in SHANK3-silenced cells failed to rescue the increase in integrin activation triggered by loss of SHANK3 (Fig. 3b ). In contrast, re-expression of Shank3 WT in the same cells completely restored integrin activity back to control The Tukey box plots represent the median and the 25th and 75th percentiles (interquartile range); points are displayed as outliers if 1.5 times above or below the interquartile range; outliers are represented by dots. Statistical analysis: Student's t-test. Statistics source data can be found in Supplementary Table 3 . Supplementary Table 3 . levels ( Fig. 3b ). Furthermore, overexpression of the SPN domain alone (SPN WT) was sufficient to significantly inhibit integrin activity in CHO cells (Fig. 3c ). The L68P mutation significantly, and the R12C mutation partially, impaired SPN-domain-mediated integrin inhibition ( Fig. 3c ). An intact SPN domain was also critical for the ability of SHANK3 to regulate cell adhesion ( Fig. 3d ) and cell spreading ( Fig. 3e ). Unlike SHANK3 WT, SHANK3L68P failed to rescue SHANK3-silencing-induced effects on these processes. Thus, an intact SPN domain is a prerequisite for SHANK-dependent inhibition of integrin activity and the L68P mutation is more disruptive to SPNdomain activity than the R12C mutation. Given the apparent functional importance of the ASD-associated SHANK3 mutations in integrin activity regulation, we investigated the effects of SHANK3 WT and L68P mutant in neurons. Overexpression of SHANK3 WT, but not the L68P mutant, in Shank3αβ −/− cortical neurons plated on laminin inhibited β1-integrin activity in neuronal growth cones, structures regulated by integrins and integrin downstream signalling 35, 36 (Fig. 3f,g ). In addition, expression of SPN WT, but not SPNL68P, inhibited integrin activity in the growth cones of differentiating neuroblastoma cells on laminin ( Supplementary  Fig. 3a,b ). Thus, SHANK3 inhibits β1-integrins also in neuronal cells.
Three-dimensional structure of the SHANK SPN-ARR region
To gain further insight into the role of the SHANK SPN domain in regulating integrin activity we determined the structure of the SPN-ARR region (the SPN domain is likely to form a compact unit with the adjacent ARR domain through intramolecular interactions 32 ) by crystallizing the N-terminal fragment of SHANK3 (residues 1-348) and solving the structure by molecular replacement using two repeats from the core ankyrin domain of the crystal structure of human ankyrin-R (Protein Data Bank (PDB) ID: 1N11) as a template. The resulting structure, containing only 1 chain in the asymmetric unit and comprising residues 2-347 of SHANK3, was refined to 2.2Å; no electron density was detected for residues 1 and 348. Data collection and refinement statistics are given in Supplementary Table 1 .
The structure of the SPN-ARR fragment demonstrated two distinct domains separated by a 19-residue linker with a well-defined conformation (Fig. 3h ). The carboxy-terminal ARR domain (residues 113-337) consists of seven canonical helix-turn-helix-β-hairpin/loop ankyrin repeats arranged in a curved solenoid structure. The loop region of each repeat forms a β-hairpin extending at 90 • angle from the helices towards the centre of the solenoid, typical for ARR domains 37 . The β-hairpins of the repeats form a continuous flat surface that covers one end of the solenoid structure. The SPN domain (residues 8-93) positioned on top of the ARR β-hairpin surface has a ubiquitin-like fold (Ubl) closely resembling the Ubl within the talin F0 domain 38, 39 ( Fig. 3i and Supplementary Fig. 3c ). The SPN domain makes charged and polar contacts with the outer surface of the β-hairpins of repeats 2 and 3 (Fig. 3j ). The N-terminal part of the linker region connecting the SPN and ARR domains runs along the ARR β-hairpin surface, making a range of polar contacts (Fig. 3j ). The C-terminal region of the linker folds into a 2-turn α-helix that packs against the outer end of the ankyrin repeat 1.
NMR studies confirmed that the SPN-ARR region of SHANKs exists as an integrated unit in solution (see Supplementary Fig. 3d for the data and a detailed description).
Structure of SHANK3 SPN-ARR reveals a previously uncharacterized Ras/Rap-association (RA) domain
The similarity between the SHANK SPN and talin F0 structures, and the reported interaction between talin F0 and Rap1 39, 40 , prompted us to investigate whether SHANK SPN is an RA domain interacting with Ras and Rap GTPases. Sequence alignment of SHANK1 and SHANK3 SPN domains with the well-characterized RA domains of RalGDS, Raf and Byr revealed the presence of consensus Ras/Rap-recognizing positive charges (residues Arg12 and Lys22) in the β1 and β2 strands of both SHANK1 and SHANK3 isoforms and a distinctive distribution of hydrophobic residues in the same region that are typically associated with RA domains 41 (Fig. 4a ). Furthermore, the Ras/Rap recognition side chains of the SPN and RalGDS RA domains are well aligned in space (Fig. 4b ). The only deviation from the consensus is the substitution of a positive charge, corresponding to position 52 in RalGDS, with an alanine in SHANK1 and SHANK3. However, other exposed positive charges (Arg38 or Arg25) in the vicinity of Arg12 and Lys22 may compensate for the missing charge in the α1-helix of the SHANK proteins ( Fig. 4b,c ). These data strongly suggest that SHANK SPN belongs to the RA family of Ubl domains.
The SHANK SPN domain is a functional RA domain as it coimmunoprecipitated with WT and constitutively active (G12V mutant) forms of H-Ras but not with the dominant-negative H-Ras S17N variant ( Fig. 4d ). Thus, SHANK3 preferentially binds to the GTPbound, active H-Ras. Additionally we found that the SHANK3 SPN domain interacts with several Ras and Rap proteins in their constitutively active and WT forms ( Fig. 4e ). However, in line with the notion that RA domains are promiscuous in terms of binding to several different Ras family members, but not Rho G proteins, SHANK3 SPN did not interact with Rac1-GTP or Cdc42-GTP ( Supplementary Fig. 4a ).
Autism-associated mutations in SHANK3 SPN impair Ras and Rap binding
Next we predicted the potential effects of ASD-related mutations by superimposing the SHANK3 SPN structure on the RalGDS RA domain in complex with Ras (PDB ID: 1LFD). The model demonstrated that most of the key ion-pair and polar interactions at the interface are preserved in SHANK3. In this model the position of the SHANK3 SPN Arg12 side chain is optimal for forming an ion pair with Glu37 of Ras ( Fig. 4f ). Thus, the R12C mutation identified in ASD is expected to significantly reduce Ras binding. The second ASD mutation in the SPN domain, L68P, affects one of the key residues of the hydrophobic core ( Fig. 3h ) and is expected to disrupt the SPN fold, potentially causing loss of Ras interaction. As predicted from these structural analyses, the R12C and L68P ASD mutations within the SPN domain disrupted SHANK3 SPN domain interaction with active (G12V mutant) Ras as well as Rap1 variants (Fig. 4g ,h), even though SPN R12C retained partial binding to Rap1b in pulldowns ( Fig. 4g,h) .
Accordingly, isothermal titration calorimetry (ITC) measurements with purified recombinant proteins indicated a very strong interaction between SHANK3 SPN-ARR and Rap1b-GTP (K d = 0.2 ± 0.05 µM) ( Fig. 4i ). In comparison the K d for SPNR12C-ARR binding to Rap1b was 2.2 ± 0.26 µM, indicating a tenfold reduction in affinity towards Rap1b (Fig. 4j ), in line with the immunoprecipitation and modelling data. The interaction between WT SPN with H-Ras-GTP was weaker (K d = 3.3 ± 0.14 µM) ( Supplementary Fig. 4b ) and further I G I  I I RVSL  I RVFL  T  72 -LR F I A  β1  β2  α1   I   s  19 -19 -29 - Supplementary Table 3 . reduced in the presence of the R12C mutation, and no interaction was observed with H-Ras-GDP ( Supplementary Fig. 4c-e ). The interaction between SHANK1 SPN and H-Ras-GTP, although weaker (K d = 5.9 ± 0.73 µM), was within the range of affinities determined for RA domains ( Supplementary Fig. 4f ) 41 . The enthalpy of SHANK3 SPN interaction with Rap1-GTP was significantly lower than that observed with H-Ras-GTP ( Supplementary Fig. 4g ), suggesting stronger ionpair interactions or formation of additional hydrogen bonds at the interface between the SHANK SPN domain and Rap1-GTP. We could not ascertain the effect of the ASD-related L68P mutation in ITC experiments as we were unable to produce soluble mutant protein. However, this insolubility may point towards a role for Leu68 in the folding of the SPN domain. Taken together these data indicate that the SPN domain of SHANK interacts with Ras and Rap in a manner similar to other RA-domain-containing proteins and that the primary effect of ASD mutations is a loss of interaction with small G proteins.
SHANK3 interferes with integrin activation by sequestering Rap1a and R-Ras
The active small GTPases Rap1 4,42-45 and R-Ras 46-48 activate integrins via inside-out signalling. To explore whether β1-integrin inhibition by SHANK3 is Rap1-and R-Ras-dependent we performed the flow cytometric-based integrin activity assays in HEK293 cells. Expression of a constitutively active Rap1a (Rap1Q63E) or constitutively active R-Ras (R-RasG38V) enhanced integrin activity ( Fig. 5a and Supplementary Fig. 5a ). Co-expression of Shank3-mRFP inhibited the ability of both Rap1Q63E and R-RasG38V to augment β1-integrin activity, which was comparable to control levels ( Fig. 5a and Supplementary Fig. 5a ). The ability of Mn 2+ to induce integrin outside-in activation is dependent on active Rap1 availability in cells 49 . Accordingly, we find that Mn 2+ -induced integrin activity is significantly impaired in Shank3-mRFP-overexpressing CHO cells ( Supplementary Fig. 5b ). Active Rap1a-induced integrin Unprocessed original scans of blots are shown in Supplementary Fig. 8 .
activation promotes marked cell spreading and flattening 50 . Consistent with the ability of SHANK3 to attenuate Rap1-dependent integrin activation, co-expression of SHANK3 with Rap1 fully reversed the cell spreading phenotype (Fig. 5b,c) . Notably, the Rap-bindingdefective Shank3L68P and Shank3R12C mutants failed to counteract Rap1Q63E-or R-RasG38V-mediated integrin activation ( Fig. 5a and Supplementary Fig. 5a ). In hippocampal neurons integrin ligands stimulate 51 and SHANK3 overexpression suppresses 52 the formation of new filopodia. We found that overexpression of Shank3 WT-GFP, but not the L68P mutant, inhibits filopodia number in MAP2-positive rat hippocampal neurites (Fig. 5d,e ). Furthermore, WT SPN-GFP overexpression reduced filopodia number in neurites of differentiating neuroblastoma cells in comparison with GFP ( Fig. 5f,g) . However, the number of neurites, in addition to neurite length and branching, was not significantly affected by SHANK3 WT or L68P overexpression ( Supplementary Fig. 5c ), in agreement with the normal brain architecture reported for most Shank3-deficient mouse models 53 . Importantly, pharmacological inhibition of Rap1 54,55 reverted integrin activity ( Fig. 5h ) and cell spreading (Fig. 5i,j) in SHANK3-silenced cells back to control levels, suggesting that SHANK3 regulates integrin activity and cell spreading in a Rap1-dependent manner. These data suggest that SHANK3 antagonizes Rap1a-and R-Ras-induced integrin activation and signalling. Rap1-GTP targeting to the plasma membrane is essential for RIAM recruitment and talin-mediated integrin activation 4 . In line with the ability of SHANK3 to counteract active Rap1-dependent signalling in cells, we found significant co-localization between Shank3-mRFP and Rap1Q63E-GFP especially in membrane ruffles of cells (Fig. 6a) . In addition, SHANK3 silencing in cells markedly increased Rap1 levels in the plasma membrane fraction (Fig. 6b ) and triggered a marked enrichment of active Rap1 (Raichu-Rap1 fluorescence resonance energy transfer (FRET) probe 56 ) at the cell periphery close to the plasma membrane compared with a more uniform distribution of active Rap1 in control cells ( Fig. 6c-e ). This was due to altered Rap1 localization in cells as total Rap1-GTP levels were not significantly altered following SHANK3 silencing ( Supplementary Fig. 6 ). Thus, SHANK expression appears to regulate the bioavailability of active Rap1 particularly on the plasma membrane.
SHANKs reduce integrin-talin complexes and regulate adhesion dynamics in cells
Interestingly, using the proximity ligation assay (PLA), we observed that SHANK3 silencing also promotes talin recruitment to β1-integrin ( Fig. 7a,b ). Furthermore, endogenous talin co-immunoprecipitated with β1-integrin more efficiently in SHANK3-silenced cells (Fig. 7c; 2.1 ± 0.7 fold increase, n = 3). Live-cell imaging revealed that depletion of SHANK1 significantly enhanced talin recruitment to newly forming membrane protrusions in MDA-MB-231 cells (Fig. 7d,e and Supplementary Video 2). In addition, SHANK1 silencing reduced the lifetime of paxillin-positive focal adhesions (Fig. 7f,g) , corroborating our data from fixed cells displaying more small adhesions and faster cell spreading. Altogether, these data suggest that SHANKmediated segregation of Rap1 away from the plasma membrane affects talin recruitment to integrin tails and thus impedes integrin activation. However, whether SHANKs directly affect Rap1-RIAMtalin complex formation remains to be investigated.
SHANK3 attenuates cell migration and invasion
Increased integrin activity is implicated in altered cell migration as well as enhanced cancer cell invasion and metastasis 7, 57, 58 . To assess the role of SHANKs in cell migration we analysed motility of SHANK -silenced cells in two dimensions. Time-lapse imaging revealed that depletion of SHANK3 in HEK293 cells or SHANK1 in MDA-MB-231 cells promotes a significant increase in migration velocity and a converse decrease in directionality of migration (Fig. 8a-c and Supplementary  Fig. 7a-c) . The effect of SHANK1 silencing on migration was fully reversed following re-expression of Shank1-GFP ( Fig. 8d-e ). Previous work has linked increased random motility in two dimensions to enhanced cancer cell invasion in three dimensions 59 . In line with this notion we observed that SHANK1 silencing significantly promoted cell invasion into collagen hydrogels (Fig. 8f,g) . Thus, increased integrin activity in SHANK -silenced cells promotes cell spreading, random migration and three-dimensional invasion demonstrating that SHANKs are biologically important regulators of integrin function.
DISCUSSION
Regulation of integrin activity is of central importance to human health 1 . The critical role of Rap1 in the final steps of integrin activation is well established 5 ; active Rap1 recruits RIAM and talin to the plasma membrane to facilitate integrin activation. However, mechanisms to fine-tune this activation or to antagonize it are not fully understood.
Here we describe that the scaffold proteins SHANK1 and SHANK3 act as negative regulators of integrin activity in several cell types and consequently interfere with cell adhesion, spreading, migration and invasion (Fig. 8h) , and with filopodia formation in neurites. Furthermore, we demonstrate that ASD-linked SHANK3 mutants are functionally deficient in binding to the active Ras family members Rap1 and R-Ras and in mediating integrin inhibition.
The crystal structure of the SHANK3 N-terminal SPN-ARR region confirmed the intramolecular interaction between both domains detected previously 32 . More importantly, it allowed us to elucidate the molecular mechanism by which SHANKs regulate integrin activity: the SPN is an RA domain most similar to the N-terminal F0 motif of talin; the SHANK SPN domain binds active, GTP-bound forms of H-Ras, Rap1 and other Ras subfamily members with high affinity; ASD-related mutations in residues Arg12 and Leu68 in the SHANK3 SPN domain impair binding to Ras proteins and the ability to antagonize β1-integrin activity in cells. Thus, the primary mechanism of SHANK-dependent integrin antagonism most likely stems from the ability to interfere with Rap1 or R-Ras effector binding through direct competition (Fig. 8h ). It is important to note that, unlike the specific integrins expressed on leukocytes or platelets, Rap1 is not absolutely essential for β1-integrin activation and a significant pool of β1-integrin remains active in adherent cells even once Rap1 is inhibited 1, 7 . Thus, several pathways, in addition to the Rap1-RIAMtalin axis, are likely to be involved in the spatio-temporal fine-tuning of β1-integrin activity in adherent cells at any given time.
ECM ligands and specific adhesion receptors such as integrins are also important in the central nervous system, in dendritic spines and synapses 60 . Autism-like deficits of Shank3-deficient mice can be rescued by targeting the actin regulators Rac and cofilin 20 , by reexpressing Shank3 in adult mice 21 or by inhibiting Akt signalling 19 . Given the ability of integrins to regulate all of these proteins, our identification of a potential role for SHANK proteins in regulating integrin activity in neuronal growth cones is most likely relevant to the neurodevelopmental disorder of these mice.
Our observation that SHANKs antagonize integrin activation, by limiting active Rap1 bioavailability on the plasma membrane, provides a significant advance to our understanding of integrin activity regulation. However, SHANK3-mediated control of Ras and Rap may contribute to integrin-independent pathways as well. SHANK3 is a major scaffold protein within the PSD of dendritic spines 61 . Ras activation promotes spine growth, while Rap1 induces spine shrinkage 62 . Thus, sequestration of the activated forms of G proteins may contribute to maintaining the balance between Ras and Rap1 activities given that the R12C mutation compromises the effect of SHANK3 overexpression on spine size and synaptic transmission 52, 63 . Furthermore, the ability of SHANK1 and SHANK3 to sequester active Ras and Rap family members is likely to be important in other biological contexts including Ras-driven human carcinomas.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of this paper. Isolation of mouse mammary gland cells. Primary mouse mammary stromal fibroblasts (MMFs) and mouse mammary epithelial cells (MMEC) were isolated from the mammary glands of adult (17-25 week old) virgin female mice. Briefly, the second, third, fourth and fifth mammary glands from three wild-type and Shank3αβ −/− mice per experiment were removed aseptically without lymph nodes, minced with surgical blades, and incubated in a shaker for 2 to 3 h at 37 • C in 25-30 ml of digestion media (DMEM/F12, 5% FBS, 5 µg ml −1 insulin, 50 µg ml −1 gentamicin) containing 2 mg ml −1 collagenase type XI (Sigma). The cell suspensions were centrifuged for 10 min at 400g to eliminate floating fat cells. Cell pellets were resuspended in isolation media (DMEM/F12, 50 µg ml −1 gentamicin, penicillin/streptomycin) with 20 U ml −1 DNase I (Roche) and incubated for 3 min at room temperature with occasional shaking. Cells were pelleted and disaggregated by pipetting up and down 10 times in 10 ml of isolation media. After each round of pulse centrifugation at 400g , the supernatant containing single cells was collected and pooled. After four rounds of pulse centrifugation, the pellet containing mammary epithelial ducts was collected. MMECs were trypsinized and pushed through a cell strainer (70 µm, 352350 BD Biosciences) to obtain single cells. The supernatants containing MMFs were also pelleted, and resuspended in fibroblast growth media (DMEM/F12, 5% FBS, L-glutamine, penicillin/streptomycin). MMEC and MMF cell suspensions were fixed with 4% paraformaldehyde (PFA) for 10 min at room temperature and resuspended in PBS.
Primary neuron culture and transfection. For preparation of primary hippocampal and cortical neurons from E20 rat embryos or E16 Shank3αβ −/− mice, embryonic brain tissue was dissected, and neurons were recovered by enzymatic digestion with trypsin and mechanical dissociation. Cells were maintained in Neurobasal medium supplemented with 2% B27 supplement, 0.5 mM L-glutamine, 0. cDNA constructs. Rat Shank3-mRFP WT, Shank3R12C-mRFP, Shank3L68P-mRFP and rat Shank1-GFP were used in this study. WT and mutant (L68P, R12C) rat Shank3/ProSAP2 cDNAs have been described earlier 32 . There are two alternative translation start codons in this cDNA (acc. NM_021675); we refer here to the second start codon as codon 1, so that the codon for Arg12 in the rat Shank3 cDNA corresponds to the (mutated) codon for Arg12 in the human SHANK3 gene. cDNAs were subcloned into pmRFP-N3 in frame with the mRFP coding sequence for expression of C-terminal mRFP-tagged Shank3 variants. In addition, pHAGE-EGFP-Shank3 (rat) was supplied by A. Shcheglovitov (Stanford, California, USA). The L68P mutation was introduced using the QuikChange II mutagenesis kit (Agilent). For expression of GFP-tagged SPN domain, the sequence coding for the rat Shank3 SPN domain was cloned into pEGFP-C1 (Clontech). For the expression of His6-SUMO-tagged fusion proteins of N-terminal portions of Shank proteins, appropriate cDNA fragments were amplified by PCR using wt or mutant Shank cDNAs as a template, and cloned into pET-SUMO vectors (Champion pET SUMO Protein Expression System, Invitrogen). Protein expressed from pET-SUMO-Shank3 1-348 was used for crystallization and binding assays. For introduction of a cleavage site for the tobacco etch virus (TEV) protease, cDNA coding for amino acids SSENLYFQGSS was introduced into this vector between codons for Asn100 and Leu101 by a recombinant PCR approach. Human H-Ras was cloned into pOPINJ vector (OPPF-UK) encoding an N-terminal hexa-histidine GST tag followed by 3C protease cleavage site. Rap1 isoform Rap1b (residues 1-166) was cloned into pTAC vector. cDNAs coding for human Rac1 or cdc42 were amplified by PCR and cloned into a modified pcDNA3 vector (Invitrogen) with an N-terminal T7 epitope. Constitutively active mutants were generated by PCR (initially described in ref. 64) . Human SHARPIN-GFP has been described in ref. 7 . Human constitutively active R-Ras expression clone (pEGFP-R-RasG38V) 48 Antibodies, compounds and reagents. Antibodies used in the study are described in Supplementary Table 2 . Phalloidin-Atto 647N (65906, Sigma-Aldrich, 1:400) and Alexa Fluor 488 phalloidin (A12379, Life Technologies, 1:100) were used to stain filamentous actin. Alexa Fluor-conjugated secondary antibodies (488, 555, 633, 647conjugated anti-mouse, rabbit, goat, chicken and rat antibodies, Life Technologies) were used in immunofluorescence (1:300 or 1:1,000 (anti-chicken)) and FACS (1:200). The 4 6-diamidino-2-phenylindole (DAPI, Life Technologies 1:10,000) or DAPI-containing mounting medium (ProLong Diamond Antifade Mountant with DAPI, Thermo Fisher) was used for nuclear staining. The bovine plasma fibronectin (341631) was obtained from Merck. The collagen from calf skin (C8919), poly-L-ornithine solution (P4957) and laminin (L2020) were obtained from Sigma-Aldrich. The laminin-521 was obtained from BioLamina. Rap1 inhibitor, G5169-GGTI 298 trifluoroacetate salt hydrate (Sigma-Aldrich), was dissolved in sterile dimethylsulfoxide (DMSO).
High-density cell-spot microarray screening and Clustergram.
The cell-spot microarray screening is described in ref. 22 . Here, the results of integrin activation using SHANK1 and SHANK3 siRNAs are shown. Z scores were hierarchically clustered on the basis of uncentred Pearson correlation using Cluster 3.0 (C Clustering Library, version 1.50) 66 and visualized using Java TreeView (version 1.1.6r2) 67 . RWPE1: immortalized prostate cell line; PrEC, PrSC: primary prostate cells; ALVA31, PC3, MDA-PCA2b, 22-RV1 and VCaP1: prostatic cancer cell lines; A549 and NCI-H460: lung carcinoma cells; MDA-MB-231: breast carcinoma cell line; HTC116 and SW480: colon carcinoma cell lines.
GTEx portal analysis. SHANK3 gene expression in human tissues was analysed using the publicly available genotype-tissue expression (GTEx) portal (http:// www.gtexportal.org/home/gene/SHANK3).
Quantitative real-time polymerase chain reaction (qPCR).
Total cellular RNA was extracted using the NucleoSpin RNA kit (Macherey-Nagel) and 1 µg of the extracted RNA was used as a template for cDNA synthesis by high-capacity cDNA reverse transcription kit (Applied Biosystems) according to the manufacturer's protocol. Expression levels of SHANK 1 and 3 were determined by TaqMan qPCR reaction using Real-Time PCR HT7900 (Applied Biosystems). Level of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) expression was used as a reference (endogenous control).
Taqman Universal Master Mix II included necessary components for qRT-PCR reaction. The following primers from Sigma were used for human samples: SHANK1 (forward CTCCCTGCGTTCCAAATGTA, reverse GGCTGCTGCTCGTACTCC, Universal ProbeLibrary probe No. 25); SHANK3 (forward TTCCACGGACCAAG TCTGTA, reverse GTCTTGCATCGAGGTGCTC, probe No. 11); human GAPDH (forward GCTCTCTGCTCCTCCTGTTC, reverse ACGACCAAATCCGTTGACT C, probe No. 60). Relative expression was calculated by the 2 CT method using the expression level of GAPDH as a reference for the quantification.
Western blot assay. Protein extracts were separated on SDS-PAGE under denaturing conditions (4-20% Mini-PROTEAN TGX Gels, Bio-Rad) and transferred to nitrocellulose membrane. Membranes were blocked with 5%-milk-TBST and incubated with the indicated primary antibodies overnight at 4 • C followed by fluorophore-conjugated or Amersham ECL HRP-linked secondary antibodies at room temperature for 1 h. Membranes were scanned using an Odyssey infrared imaging system (Odyssey; LI-COR Biosciences) or Amersham ECL Plus Western blotting reagent was used and film was developed. Band intensity was determined using ImageJ software.
Flow cytometry assays for β1-integrin activity. The flow cytometry assay analysing labelled fibronectin (fibronectin) repeat 7-10 binding as a measure of active cellsurface β1-integrin levels was performed as described earlier 23, 24 . Cells were detached with Hyclone HyqTase (cat: SV300.30.01, Thermo Fisher Scientific Inc) and washed once with full medium containing 10% FBS. The cells were suspended in 100 µl of 37 • C serum-free medium with: 1:50 Alexa Fluor 647-labelled fibronectin fragment 7-10 (fibronectin 7-10); 1:50 fibronectin 7-10 supplemented with 5 mM EDTA (the negative control); or total β1-integrin antibody (PB1 for hamster cells, P5D2 for human cells, MAB1997 for mouse cells) and 1:200 Alexa-647-conjugated secondary antibody. Cells were incubated with rotation for 40 min at room temperature. After washing once with cold Tyrode's buffer (10 mM Hepes-NaOH pH 7.5, 137 mM NaCl, 2.68 mM KCl, 0.42 mM NaH 2 PO 4 , 1.7 mM MgCl 2 , 11.9 mM NaHCO 3 , 5 mM glucose, 0.1% BSA), the cells were fixed with 4% PFA in PBS for 10 min at room temperature.
For antibody-based analysis of active β1-integrin cell-surface levels, the flow cytometry assay was performed as described earlier 68 . Briefly, PFA-fixed cells were washed with cold Tyrode's buffer and stained with active β1-integrin specific antibody (1:100 9EG7 for human/mouse cells) or total β1-integrin antibody (P5D2 for human and Mab1997 for mouse cells) for 1 h at 4 • C. Cells were washed with Tyrode's buffer and followed by incubation with fluorescently conjugated secondary antibody for 1 h at 4 • C. The negative control cells were stained only with secondary antibody. All antibodies were diluted into Tyrode's buffer. The fluorescence was measured by flow cytometry (FACScalibur or LSRFortessa, BD Biosciences). The median fluorescence intensity was measured from 5,000-20,000 events. Viable, single cells were gated by forward scatter (FSC) and side scatter (SSC) dot blot (Flowing Software 2.5.1). In experiments using mRFP and/or GFP constructs the mRFP-and/or GFP-expressing cells were gated (5,000 positive cells per sample) and analysed for APC (Alexa 647) intensity.
Membrane fractionation. Adherent cells (one 10 cm dish per condition) were washed with PBS and scraped in 500 µl of hypotonic lysis buffer (10 mM HEPES-KOH pH 7.2, 0.25 M sucrose, 1 mM EDTA, 1 mM MgOAc and protease and phosphatase inhibitors (Complete and PhosSTOP tablets from Roche)). Cells were fragmented about 20 times with a French press and 40 µl of total lysate was saved. The remaining lysate was centrifuged at 1,000g for 10 min to remove nucleus and cell debris. The supernatant was then centrifuged at 10,000g to collect total membrane fraction (pellet) and cytosolic fraction (supernatant). The membrane fraction was washed at least once with lysis buffer and the cytoplasmic fraction was centrifuged twice. All fractionation steps were performed at 4 • C or on ice. All fractions were dissolved in sample buffer for immunoblotting and analysed by SDS-PAGE followed by western blotting with the indicated antibodies.
Adhesion assay using xCELLigence real-time cell analysis (RTCA). The real-time xCELLigence cell analyser RTCA (Roche Diagnostics) was used to measure cell adhesion over time. RTCA measures the impedance that is expressed as a cell index. Cell index value presents the impedance between electrodes (bottom sensors). The 96-well E-plate (Roche) was coated with fibronectin and collagen or 0.1% BSA (Gibco) in PBS, followed by blocking with 0.1% BSA in PBS, both at 37 • C for 1 h. BSA-coated wells were used as negative controls. siRNA-treated and/or transfected cells (HEK293 or MDA-MB-231) were detached with Hyclone HyqTase, washed with full medium including 10% FBS and 20,000 cells per well were seeded on E-plates in serum-free medium. Cell index was measured in real time.
Cell spreading and immunostaining. siRNA-treated and/or transfected cells (HEK293, MDA-MB-231) were maintained in full medium and were allowed to spread for 20 min or 1 h on glass-bottom dishes (MatTek corporation) previously coated with fibronectin and collagen overnight at 4 • C. Transfected SK-N-BE-2 cells were plated on laminin-521-coated glass-bottom dishes and differentiated using 10 µM retinoid acid in full medium for 3 days. To study the role of Rap1 in SHANK3silenced cells, cells were pre-treated with 10 µM Rap1 inhibitor (or DMSO) and plated for 1 h on fibronectin-collagen in the presence of the inhibitor (or DMSO). Cells were fixed with 4% PFA, washed, permeabilized with 0.5% Triton X-100 for 10 min and blocked with 1 M glycine for 30 min at room temperature. Cells were washed and then stained with the indicated primary antibodies diluted in PBS (1:100) for 30 min at room temperature. Cells were then washed and incubated with Alexa-conjugated secondary antibodies (1:300), phalloidin-Atto 647N (1:400) or Alexa Fluor 488 phalloidin (1:100), and 4 6-diamidino-2-phenylindole (DAPI, nuclei staining, 1:10,000) in PBS for 30 min at room temperature.
Transfected neurons were plated at a density of 4,000 mm −2 (hippocampal) or 20,000 mm −2 (cortical) on 18-mm glass coverslips previously coated with 0.01 % poly-L-ornithine solution (Sigma-Aldrich) for 1 h at room temperature, followed by 4 µg ml −1 laminin (Sigma-Aldrich) in PBS overnight. Cultures were maintained at 37 • C, 5% CO 2 in a humidified incubator. Neurons were fixed at DIV1 with 4% paraformaldehyde/4% sucrose in PBS for 15 min and permeabilized with 0.1% Triton X-100 in PBS for 3 min at room temperature. Rat neurons were blocked with 10% horse serum in PBS for 1 h at room temperature, and then incubated with Map2 (antibodies-online; 1:1,000 in 2% horse serum) overnight at 4 • C, followed by 1 h of incubation at room temperature with Alexa-conjugated secondary antibody (1:1,000 in PBS) and with 547-phalloidin (1:40 in PBS) for 20 min at room temperature. Nuclei were stained with DAPI-containing mounting medium (ProLong Diamond Antifade Mountant with DAPI, Thermo Fisher). Mouse neurons were blocked with 1 M glycine for 30 min at room temperature, washed and stained using the indicated primary antibodies diluted in PBS (1:100) for 25 min at room temperature. Cells were then washed and incubated with Alexa-conjugated secondary antibodies (1:300).
Finally, cells were washed and imaged with a confocal microscope. Cell area was analysed using ImageJ and the number and size of active integrin (9EG7)positive cell adhesions were analysed using the Cell Profiler software. Co-localization analyses were performed using the NIH ImageJ Plugin JACop.
Micropatterns. Micropatterns were produced on glass coverslips as previously described 69, 70 . Cells were seeded on collagen-fibronectin-coated micropattern lines (width 9 µm) for either 20 min or 60 min (cells on line) before fixing with 4% PFA. Samples were stained as described above.
FRET analysis of active Rap1 localization. siRNA-treated HEK293 cells transiently expressing Raichu-Rap1 FRET probe 71, 72 were plated on fibronectin-collagen-coated glass-bottom dishes for 1 h at 37 • C. Cells were then fixed in 4% PFA, washed with PBS and blocked in a solution of 1 M glycine for 30 min. Cells were then imaged with a confocal microscope (LSM780, Zeiss) using a 63× (NA 1.2 W) objective. The ZEN imaging software was used to generate and export the Fc images with intensities converted from the FRET index calculated for each pixel using the Youvan method. FRET ratio at the cell edge and cell body was quantified using NIH ImageJ and Cell Profiler software.
Proximity ligation assay (PLA). PLA detection of α5-integrin-talin interaction was performed as previously described 68 . Briefly, siRNA-treated HEK293 cells were maintained in full medium and were allowed to spread for 20 min on glass-bottom dishes (MatTek corporation) previously coated with fibronectin-collagen overnight at 4 • C. The coverslips were washed with PBS, fixed with 4% PFA for 15 min, washed twice with PBS and permeabilized with 0.5% Triton X-100 in PBS for 15 min at room temperature. Cells were stained using the indicated primary antibodies diluted in PBS (1:100) for 1 h at room temperature. Proximity ligation was performed according to the manufacturer's instructions (Duolink in situ PLA, Sigma-Aldrich). PLA signals were detected with a spinning-disc confocal microscope (Marianas spinning-disc imaging system, Intelligent Imaging Innovations) using a 100× objective (NA 1.4 oil, Plan-Apochromat, M27) and analysed with NIH ImageJ.
Live-cell imaging. To analyse the dynamics of focal adhesions, cells were transfected with mEmerald-paxillin (a gift from M. Davidson, Addgene plasmid No. 54219) and plated for at least 6 h on fibronectin-collagen before being imaged live on a TIRF microscope, at 37 • C, in the presence of 5% CO 2 . Images were acquired every minute for at least 3 h, using a 63× (NA 1.46 oil, alpha Plan-Apochromat, DIC) objective and an internal Optovar (1.6× magnification). Acquired videos were pre-processed using ImageJ and in particular, the contrast was adjusted and a smooth filter was applied. Focal adhesion lifetime was then analysed by uploading the videos to the focal adhesion analysis server (FAAS; http://faas.bme.unc.edu) 73 using the following settings: detection threshold, 2; Min Adhesion Size, 2 pixels; Min FA, Phase Length (8 min); Min FAAI Ratio, 3.
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To analyse the dynamics of talin-containing adhesions, cells were transfected with GFP-Talin-1 and plated on fibronectin-collagen before being imaged live on a TIRF microscope, at 37 • C, in the presence of 5% CO 2 . Images were acquired every minute for at least 3 h, using a 63× (NA 1.46 oil, alpha Plan-Apochromat, DIC) objective and an internal Optovar (×1.6 magnification).
To visualize Shank3 dynamics, cell were transfected with Shank3-mRFP and plated on fibronectin-collagen and imaged live on a spinning-disc microscope, at 37 • C, in the presence of 5% CO 2 . Images were acquired every 10 s for about 10 min, using a 100× (NA 1.4 oil, Plan-Apochromat, M27) objective and Evolve 512 EMCCD camera (Photometrics).
Cell migration. siRNA-treated and/or transfected cells (MDA-MB-231 or HEK293) were seeded on fibronectin-collagen and allowed to spread for 4 h. Cells were maintained at 37 • C and 5% CO 2 and cell migration was monitored using a TIRF microscope (10× objective). Point visiting was used to allow multiple positions to be imaged within the same time course and images were acquired for 24 h (one picture every ten minutes). To assess cell migration, speed and directionality, cells were tracked using the Manual Tracking plugin of NIH ImageJ software. Results were computed and analysed by the NIH ImageJ plugin Chemotaxis Tool.
Inverted invasion assay. Inverted invasion assay was performed as previously described 74 . In brief, 200 µl of collagen I (5 µg ml −1 ; PureCol EZ Gel, Cat. No. 5074-G, Advanced BioMatrix) supplemented with 25 µg ml −1 fibronectin was allowed to polymerize in each Transwell chamber, that is, insert (ThinCert, pore size 0.8 µm, Greiner bio-one), for 1 h at 37 • C. Transwells were then inverted, and 100,000 MDA-MD-231 cells in full medium were seeded directly onto the underside of each Transwell filter. The droplets of cell suspension were covered and incubated for 4 h at 37 • C in a humidified incubator to allow cells to attach to the membranes. Transwell chambers were then washed with serum-free medium to remove serum. Finally, Transwells were placed in serum-free medium, and medium supplemented with 10% FCS was placed on top of the collagen plug to make a chemoattractant gradient. Transwells were incubated at 37 • C for 72 h. Then, collagen plugs were fixed with 4% PFA for 2 h and stained for actin (Atto phalloidin 647) to visualize cells. The plugs were imaged by confocal microscopy (Zeiss LSM510 META) controlled by the Zen2009 Systems Software (Carl Zeiss). Serial optical sections were imaged at 15 µm intervals with a 20× objective lens (NA 0.50 air, Plan-neofluar). Invasion was quantified using the area calculator plugin in ImageJ to measure fluorescence intensities of cells as a ratio of cells invading 45 µm or more into the collagen plug relative to total amount of cells within the plug.
Microscopy. Confocal images were acquired with a laser scanning confocal microscope LSM780 (Carl Zeiss Microscopy) using a 63× (NA 1.2 W) objective; or with a spinning-disc confocal microscope (Marianas spinning-disc imaging system with a Yokogawa CSU-W1 scanning unit on an inverted Carl Zeiss Axio Observer Z1 microscope, Intelligent Imaging Innovations) using a 63× (NA 1.4 oil, Plan-Apochromat, M27 with DIC III Prism) objective and an Orca Flash 4 sCMOS camera (Hamamatsu Photonics K.K.) or 100× (NA 1.4 Oil, Plan-Apochromat, M27) objective and an Evolve 512 EMCCD camera (Photometrics); or with LSM510 META (Carl Zeiss Microscopy) using 20× objective (NA 0.50 air, Plan-Neofluar); or with a Leica Sp5 confocal microscope using a 63× objective (NA 1.4). Images with a TIRF microscope (Zeiss Laser-TIRF 3 Imaging System, Carl Zeiss) were acquired using a 10× objective (NA 0.25 air) or a 63× (NA 1.46 oil, alpha Plan-Apochromat, DIC) objective with an internal Optovar (1.6× magnification) and an EMCCD camera (Hamamatsu ImageEM C9100-13; Chip size 512 × 512; Hamamatsu Photonics K.K.). Quantitative analysis for images was performed using ImageJ or Cell Profiler software.
Immunoprecipitation of GFP-tagged proteins. HEK293 cells were transiently transfected with GFP-tagged Shank3 SPN constructs and αT7 or HA-tagged small G proteins. Cells were lysed using IP buffer (50 mm Tris/HCl, pH 7.5, 120 mm NaCl, 0.5% Nonidet P-40, 1 mm EDTA, plus protease inhibitors pepstatin, leupeptin, and trasylol), cleared by centrifugation, and subjected to immunoprecipitation of GFP-tagged fusion proteins using GFP-trap matrix (Chromotek). Input and precipitate samples were analysed by western blot. Bands were quantified by chemiluminescence, using a Bio-Rad imager and ImageLab software (Bio-Rad). For quantification of co-precipitation efficiency, intensity of precipitate signals was divided by input signals. In a second step, the ratio obtained was normalized to that obtained with the SPN WT domain.
Immunoprecipitation of endogenous proteins. Cells were detached with trypsin, spun down and excess liquid was removed. A total of 200 µl of lysis buffer (40 mM Hepes-NAOH, 75 mM NaCl, 2 mM EDTA, 1% NP-40 and protease and phosphatase inhibitor tablets) was added (per 10 cm plate). Tubes containing the lysates were rotated for 30 min at 4 • C. Lysates were then spun down at 13,000 r.p.m. (∼16,000g ) for 10 min at 4 • C and debris was discarded. A total of 20 µl of supernatant was frozen as lysis control. The remainder of the sample was moved to new 1.5 ml tubes and 1.5 µg of antibodies added per sample. The tubes were then incubated overnight at 4 • C. Lysates were immunoprecipitated with protein G Sepharose 4 Fast Flow beads (GE Healthcare) for 1 h at 4 • C. Finally, immunoprecipitated complexes were washed three times with wash buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40) followed by elution in reducing Laemmli buffer and denatured for 5 min at 95 • C for western blotting. Rap1 activity assay. The level of active Rap1 in control and SHANK3-silenced cells was analysed using the Active Rap1 Pull-Down and Detection Kit (Thermo Fisher). siRNA-transfected HEK293 cells were lysed and active Rap1 binding to purified GST-RalGDS Rap-binding domain (RBD) was analysed according to the manufacturer's instructions using pulldowns followed by western blot detection.
Sample preparation for structural and ITC binding analysis. Rat SHANK3 (residues 1-348) was expressed using BL21 competent cells (Invitrogen) cultured in LB (Luria Broth) for crystallization and ITC, or M9 minimal medium for NMR analysis. Cells were grown at 37 • C in LB media supplemented with antibiotics to an OD 600 nm of 0.7, cells were cooled to 18 • C and induced using 300 µM IPTG (isopropyl β-D-1-thiogalactopyranoside) for 16 h. Cells were pelleted by centrifugation and resuspended in 20 mM Na 2 HPO 4 pH 7.4, 500 mM NaCl and 25 mM imidazole; cells were then treated with protease cocktail inhibitor VII (Calbiochem) and bovine deoxyribonuclease (1 mg ml −1 ) before being lysed using a French press. Proteins were purified using nickel-affinity chromatography with a linear gradient of lysis buffer containing 500 mM imidazole. SUMO tag was cleaved with recombinant His-tagged sumo protease and removed by a reverse pass on the Ni-NTA column. Following this step the SHANK3 was shown to have >95% purity by SDS-PAGE chromatography. SHANK3 was then exchanged into 20 mM Tris pH 7.4, 150 mM NaCl, 2 mM DTT (dithiothreitol) and concentrated to 6 mg ml −1 for crystallization experiments. H-Ras was expressed using Rosetta pLacI (Invitrogen) cells and purified using nickel-affinity chromatography as described for SHANK3. The GST tag was cleaved with recombinant his-tagged 3C protease and removed by a reverse pass on the Ni-NTA column. H-Ras required subsequent purification using anion exchange purification using a QFF column (GE Healthcare) and was shown to be >95% pure by SDS-PAGE chromatography. Rap1b was expressed in Escherichia coli strain CK600K. Cultures were grown at 37 • C to OD 595 nm of 0.8 and then induced with 200 µM IPTG at 18 • C overnight. Protein was purified by ion exchange, followed by gel filtration, as described in ref. 75 . The active GTP form of Ras and Rap1b was produced by nucleotide exchange as described in ref. 76 using the non-hydrolysable GTP analogue GMPPCP. The GDP form was generated by overnight incubation of GTPase in the presence of a 50-fold molar excess of GTP in the presence of EDTA to remove magnesium, followed by buffer exchange using the PD10 column (GE Healthcare). The completeness of the exchange was validated by NMR spectroscopy. X-ray crystallography. Sparse matrix crystal screening of SHANK3 (1-348) was performed using an innovadyne nanodrop screen maker at protein concentration of 6 mg ml −1 with a 200 nl drop size (1:1 ratio) using sitting drop vapour diffusion. Crystals typically appeared in over 20 conditions overnight, and thus optimization was not necessary. High-resolution data were collected on crystals grown in 0.1 M HEPES pH 7.5, 0.4 M K/Na tartrate and were vitrified using 30% ethylene glycol, 10% isopropanol. A 180 • wedge of data was collected at the Diamond Light Source (I04-1) with a non-overlapping 0.5 • oscillation width. Owing to systematic absences the data were indexed (Pointless) and integrated (MOSFLM) in p4 1 2 1 2 and then scaled (SCALA). Molecular replacement was performed using PHASER examining all enantiomorphs, implementing a fragment from an ankyrin repeat module with side chains removed from PDB:1N11. Following isotropic refinement using PHENIX.refine 77 electron density for the full ankyrin repeat was visible and modelled using COOT 78 . This revealed the presence of the SPN domain in the weighted difference map that was subsequently modelled at 1σ . The fully refined electron density map also revealed a significant amount of ethylene glycol and isopropyl alcohol from the cryo-protectant bound to the structure. These bound molecules were assigned and accounted for in the final refinement. Data reduction and refinement statistics are shown in Supplementary Table 1 .
NMR spectroscopy. NMR spectra were collected on Bruker Avance III 600 and 800 MHz spectrometers equipped with CryoProbes. Experiments were performed at 298 K in 20 mM Tris pH 7.4, 150 mM NaCl, 2 mM DTT, with 5% (v/v) 2 H 2 O. Spectra were processed with TopSpin (Bruker). Figure 3 .
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Prim.cons. These spectra show backbone HN-group signals that are highly sensitive to protein conformation and dynamics and are often called "fingerprint" spectra. Folded proteins are characterized by highly dispersed signals of uniform intensity; with the increase in molecular weight, signals broaden out due to decreased protein mobility. The uniform resonance intensity of the SPN-ARR fragments indicated that the domains move as a single unit. In comparison, the signals of the isolated domains had smaller line-width and many of the signals did not overlap with any signals in the SPN-ARR fragment, while the signal distribution patterns were similar; in contrast, for a protein consisting of independently moving domains we would expect very similar positions and line-widths of signals of isolated domain and domain within a larger fragment. These spectral differences provide further support for the compact structure of the SPN-ARR unit, where the intramolecular contacts between SPN and ARR induce chemical shifts relative to the isolated domains and lead to reduced protein mobility. In this unit the SPN domain interactions are restricted to the protein surface exposed in the double domain structure. Tukey box plots represent median and 25 th and 75 th percentiles (interquartile range); points displayed as outliers if 1. 2.5 p = 0.0103 p = 0.1913 p = 0.6309 p = 0.3902
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Supplementary Figure 5 SHANK3 regulates integrin activation and cell spreading by a Rap1/Ras-dependent mechanism a, Flow cytometric analysis of integrin activity following transient co-expression of GFP-tagged constitutively active R-Ras mutant (R-RasG38V) together with WT or mutant Shank3-mRFP in HEK293 cells. Quantification shows that Shank3 WT-mRFP overexpression inhibits R-RasG38V-mediated increase in β1-integrin activity (9EG7 / total β1-integrin). In contrast, expression of ASD-related Shank3 mutants (L68P, R12C) failed to oppose R-RasG38V-induced β1integrin activation. Data are mean ± SEM expressed relative to mRFP and GFP-expressing cells (n = 6, 6, 5, 5, 3 independent experiments from left to right; 5000 mRFP/GFP-positive cells analysed per experiment). b, Flow cytometric analysis of integrin activity shows that Mn 2+ -induced integrin activity is significantly impaired in Shank3 WT-mRFP overexpressing CHO cells. Data are mean ± SEM expressed relative to mRFP-expressing cells (n = 4, 3, 4, 3 independent experiments from left to right; 5000 RFP-positive cells analysed per experiment). c, Total neurite length, main neurite length and number of end tips analysed from mouse cortex neurons plated on laminin. Data are mean ± SEM (n = 7 independent experiments). Statistical analysis: Student's t-test. Statistics source data can be found in Supplementary Table 3 . 
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Supplementary Figure 6 SHANK3 silencing does not appear to affect total active Rap1 levels. Lysates from control and SHANK3-silenced HEK293 cells were subjected to GST-RalGDS-RBD pulldown to isolate Rap1a/b-GTP (active Rap1). Total cell lysates were blotted for total Rap1a/b to normalize for Rap1 levels. Rap1-GTP levels are not significantly altered by SHANK3 silencing. Data are mean +/-SEM (n = 3 independent experiments). Statistics source data can be found in Supplementary Table 3 . Unprocessed original scans of blots are shown in Supplementary Fig 8. Lilja et al., Supplementary Figure 7 .
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